| abstract |
Compounds of general formula (I) in which X represents a hydrogen or halogen atom or an alkyl, alkoxy or trifluoromethyl group, Y represents a hydrogen or halogen atom or an alkyl or alkoxy group, R represents a hydroxy or methoxy group or a group of general formula NR 2 R 3 in which R 2 and R 3 each represent a hydrogen atom or an alkyl, 2-methoxyethyl, 2-aminoethyl, 3-aminopropyl, 2- (dimethylamino) ethyl, 3- (dimethylamino) group propyl or 2-piperidin-1-ylethyl, or alternatively R 2 and R 3 together form a morpholinyl, pyrrolidinyl or piperazinyl ring optionally substituted at 4.n n n The compounds of the invention can be used in the treatment of conditions linked to disorders of the GABAergic transmission of GABA A receptors. |